---
title: 'Genetic risk classification for adults with AML receiving less-intensive therapies:
  the 2024 ELN recommendations'
date: '2024-08-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39133932/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240813182051&v=2.18.0.post9+e462414
source: Blood
description: The European LeukemiaNet (ELN) genetic risk classifications were developed
  based on data from younger adults receiving intensive chemotherapy. Emerging analyses
  from patients receiving less-intensive therapies prompted a proposal for an ELN
  genetic risk classification specifically for this patient ...
disable_comments: true
---
The European LeukemiaNet (ELN) genetic risk classifications were developed based on data from younger adults receiving intensive chemotherapy. Emerging analyses from patients receiving less-intensive therapies prompted a proposal for an ELN genetic risk classification specifically for this patient ...